U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07228702) titled 'Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection' on Sept. 09.
Brief Summary: This study aims to use mycobacteriophage therapy, using identified in-vitro effective Mycobacteriophage Muddy\_HRMN0052, along with combination conventional antimycobacterial therapy for their NTM pulmonary disease with Mycobacterium abscessus with goal to reduce infection burden and improve pulmonary disease
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Non-Tuberculous Mycobacterial (NTM) Pneumonia
Mycobacterium Abscessus Infection
Intervention:
BIOLOGICAL: Mycobacteriophage Muddy_HRMN0052
In-vitro effectiv...